Arca Biopharma reported $1.74M in Selling and Administration Expenses for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Amgen AMGN:US $ 1.23B 197M
Arca Biopharma ABIO:US $ 1.74M 513K
Biogen BIIB:US $ 634.9M 153M
Brainstorm Cell Therapeutics BCLI:US $ 2.86M 324K
Bristol Myers Squibb BMY:US $ 1.83B 523M
Capricor Therapeutics CAPR:US 2.72M 599.73K
Cytokinetics CYTK:US $ 33.07M 736K
Cytrx CYTR:US 51.91K 1.93M
Daiichi Sankyo 4568:JP 104.74B 14.78B
Gilead Sciences GILD:US $ 1.08B 567M
GlaxoSmithKline GSK:LN 2.68B 227M
Laboratory Of America LH:US $ 464.1M 61.7M
Myriad Genetics MYGN:US $ 110.6M 33.3M
Otsuka Holdings 4578:JP 154.5B 28.82B
United Therapeutics UTHR:US $ 79M 47.9M